Impact of congenital calcitonin deficiency due to dysgenetic hypothyroidism on bone mineral density

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 1, 2004, Pages 61-68

  Daripa, M ^a   Paula, F J A ^a   Rufino, A C B ^a   Foss, M C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone mineral density; Calcitonin; Hypothyroidism; Osteoporosis

Indexed keywords

CALCITONIN; CALCIUM; CALCIUM ION; PARATHYROID HORMONE; THYROID HORMONE;

ADULT; ARTICLE; BLOOD SAMPLING; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; BONE MINERAL; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HASHIMOTO DISEASE; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYPOTHYROIDISM; INBORN ERROR OF METABOLISM; INFUSION; MALE; STATISTICAL ANALYSIS; THYROID HORMONE SYNTHESIS;

EID: 1242284679     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000100009     Document Type: Article

References (30)

1. Peacock M, Turner CH, Econs MJ & Foroud F (2002). Genetics of osteoporosis. Endocrine Reviews, 23: 303-326.
2. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V & Weaver C (2000). Peak bone mass. Osteoporosis International, 11: 985-1009.
3. Seeman E (2002). Pathogenesis of bone fragility in women and men. Lancet, 359: 1841-1850.
4. Chambers TJ, Chambers JC, Symonds J & Darby JA (1986). The effect of human calcitonin on the cytoplasmic spreading of rat osteoclasts. Journal of Clinical Endocrinology and Metabolism, 63: 1080-1085.
5. Neradilova M, Blahosova A & Reisenauer R (1977). Acute effect of large dose of calcitonin on calcium, magnesium and inorganic phosphate levels in rat serum in correlation to differences in thyroid function. Physiologia Bohemoslovaca, 26: 331-336.
6. McDermott MT & Kidd GS (1987). The role of calcitonin in the development and treatment of osteoporosis. Endocrine Reviews, 8: 377-390.
7. Heath III H & Sizemore GW (1977) Calcitonin in normal man: differences between men and women. Journal of Clinical Investigation, 60: 1135-1140.
8. Body JJ (1993). Calcitonin: from the determination of circulating levels in various physiological and pathological conditions to the demonstration of lymphocyte receptors. Hormone Research, 39: 166-170.
9. Body JJ & Heath III H (1983). Estimates of circulating monomeric calcitonin: Physiological studies in normal and thyroidectomized men. Journal of Clinical Endocrinology and Metabolism, 57: 897-903.
10. Reginster J-Y, Denis D, Albert A, Deroisy R, Lecart MP, Fontaine MA, Lambelin P & Franchimont P (1987). One-year controlled randomized trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet, 2: 1481-1483.
11. McIntyre I, Stevenson JC, Whitehead MI, Wimalawansa SJ, Banks LM & Healy MJ (1988). Calcitonin for prevention of postmenopausal bone loss. Lancet, 1: 900-902.
12. Hurley DL, Tiegs RD, Wahner HW & Heath III H (1987). Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. New England Journal of Medicine, 317: 537-541.
13. Chesnut III CH, Silverman S, Andriano K et al. (2000). A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the PROOF study. American Journal of Medicine, 109: 267-276.
14. Kruse K, Süss A, Büsse M & Schneider P (1987). Monomeric serum calcitonin and bone turnover during anticonvulsivant treatment and in congenital hypothyroidism. Journal of Pediatrics, 111: 57-63.
15. Demeester-Mirkine N, Bergmann P, Body JJ & Corvilair J (1990). Calcitonin and bone mass status in congenital hypothyroidism. Calcified Tissue International, 46: 222-226.
16. Austin LA & Heath III H (1981). Calcitonin physiology and pathophysiology. New England Journal of Medicine, 34: 269-278.
17. Weissel M, Kainz H, Tyl E, Ogunyemi E & Woloszczuk W (1991). Clinical evaluation of new assays for determination of serum calcitonin concentrations. Acta Endocrinologica, 124: 540-544.
18. Libbey NP, Nowakowski KJ & Tucci JR (1989). C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis. American Journal of Surgery and Pathology, 13: 987-989.
19. Vierhapper H, Nowotny P, Bielglmayer CL & Gessl A (2002). Prevalence of hypergastrinemia in patients with hyper and hypothyroidism: impact for calcitonin. Hormone Research, 57: 85-89.
20. Barbott N, Guyetant S, Beldent V, Akrass A, Cerf I, Perdrisot R & Bigorgne JC (1991). Chronic autoimmune thyroiditis and C-cell hyperplasia. Study of calcitonin secretion in 24 patients. Annales d'Endocrinologie, 52: 109-112.
21. Lazaretti-Castro M, Grauer A, Raue F & Ziegler R (1990). 1,25-Dihydroxyvitamin D3 suppresses dexamethasone effects on calcitonin secretion. Molecular and Cellular Endocrinology, 71: R13-R18.
22. Zabel M & Dietel M (1991). Calcitriol decreases calcitonin secretion from a human medullary carcinoma cell line via specific receptor action. Acta Endocrinologica, 125: 229-234.
23. Naveh-Many T, Raue F, Grauer A & Silver J (1992). Regulation of calcitonin gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. Journal of Bone and Mineral Research, 7: 1233-1237.
24. Anast CS & Guthrie RA (1971). Decreased calcium tolerance in nongoitrous cretins. Pediatric Research, 5: 668-672.
25. Poloyan WR, Kazuko E, Gopalsami L, Bassali J, Lawrence AM & Poloyan E (1997). Hyperparathyroidism associated with chronic hypothyroidism state. Laryngoscope, 107: 903-909.
26. Indridason OS & Quarles LD (1999). Tertiary hyperparathyroidism and refractory secondary hyperparathyroidism. In: Favus MJ (Editor), Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 198-202.
27. Body JJ, Chanoine JP, Dumon JC & Delange F (1993). Circulating calcitonin levels in healthy children and subjects with congenital hypothyroidism from birth to adolescence. Journal of Clinical Endocrinology and Metabolism, 77: 565-567.
28. Hoff AO, Lehnen-Catala P, Thomas PM et al. (2002). Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. Journal of Clinical Investigation, 110: 1849-1857.
29. Larsen PR & Davies TF (2002). Hypothyroidism and thyroiditis. In: Larsen PR, Kronenberg HM, Melmed S & Polonsky KS (Editor), Williams Textbook of Endocrinology. Saunders, Philadelphia, PA, USA, 423-456.
30. Wiersinga WM (2001). Hypothyroidism and myxedema coma. In: DeGroot LJ & Jameson JL (Editor), Endocrinology. Vol. 2. W.B. Saunders, Philadelphia, PA, USA, 1491-1506.